Major medtech companies vied for the biggest news splash at this year’s annual meeting of the American Diabetes Association, announcing promising results from studies of patients who used their latest diabetes technology. The virtual 80th Annual American Diabetes Association Virtual Scientific Sessions, which runs through Tuesday, so far has featured news out of Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) and several smaller […]
Diabetes
Welcome to MassDevice's Diabetes Hub, your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Here are top diabetes features from MassDevice and its sister publications (and scroll down to read the latest diabetes device news from MassDevice):
+ These diabetes devices are set to launch in 2024
+ The top IVD and diabetes tech stories of 2023
+ How Dexcom designed a new “life-changing” sensor for even more people with diabetes
+ Embecta CEO sees GLP-1 opportunities as company progresses on insulin patch pump
+ The 10 biggest diabetes tech stories from 2023
Latest Diabetes News
Dexcom CEO sees a new market for continuous glucose monitors after COVID-19
Could in-hospital use of continuous glucose monitors become a new normal after the COVID-19 pandemic? Dexcom CEO Kevin Sayer thinks so. As the pandemic ramped up in March, FDA issued temporary guidance allowing increased remote monitoring of hospital patients in order to limit contact with hospital staff. The guidance included CGMs made by companies such […]
Blackstone invests $337m in Medtronic diabetes tech
Medtronic (NYSE:MDT) announced that it will increase research and development for its diabetes group through an agreement to receive $337 million from Blackstone. The significant increase in R&D funding for the diabetes group is aimed at advancing new, innovative products designed to reduce the burden of diabetes management. The companies announced the agreement at the virtual […]
Abbott FreeStyle Libre 2 iCGM FDA cleared for use in adults and children
Abbott (NYSE:ABT) announced today that it received FDA clearance for its FreeStyle Libre 2 system for adults and children ages four and older with diabetes. The Abbott Park, Ill.-based company touts its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system as the only such system with optional real-time alarms that measure glucose levels every minute […]
Medtronic touts results of latest MiniMed studies at ADA
The latest generation of the Medtronic (NYSE:MDT) MiniMed insulin pump met both safety and glycemic endpoints in a study presented today at the American Diabetes Association’s virtual annual conference. The MiniMed 780G closed-loop system is indicated for treating Type 1 diabetes in people aged 7 to 80 years old. It is designed to automate the delivery […]
Former Eli Lilly researcher joins Bigfoot Biomedical as chief medical officer
Bigfoot Biomedical has brought on Dr. Jim Malone — a 21-year clinical research veteran at Eli Lilly & Co. — as its chief medical officer, the diabetes treatment tech company said today. Malone, an endocrinologist specializing in diabetes, also spent 12 years in clinical practice. Get the full story on our sister site Drug Delivery […]
Medtronic lands CE Mark for MiniMed 780G insulin pump
Medtronic (NYSE:MDT) announced today that it received CE Mark approval in Europe for its MiniMed 780G next-generation insulin pump. The closed-loop insulin pump system is indicated for treating Type 1 diabetes in people aged 7 to 80 years old. It uses Medtronic’s SmartGuard algorithm to automate the delivery of basal insulin and correction boluses every five […]
Senseonics plummets on big Q1 losses
Senseonics (NYSE:SENS) shares took a large dip today on first-quarter losses that came in well short of the consensus forecast. The Germantown, Md.-based implantable continuous glucose monitor maker posted losses of -$42.6 million, or -21¢ per share, on sales of $31,000 for the three months ended March 31, 2020, for a 45% bottom-line slide on a […]
Dexcom lands CE Mark for G6 glucose monitor
Dexcom (NSDQ:DXCM) announced today that it received CE Mark approval in Europe for its G6 continuous glucose monitoring system. The Dexcom G6 uses a small, wearable sensor and transmitter, now indicated to be placed on the back of the upper arm, to continuously measure and send glucose levels wirelessly to a dedicated receiver or compatible smart […]
Insulet resumes next-gen Omnipod pivotal study following software issues
Insulet (NSDQ:PODD) today said it has resumed its pivotal study of its next-generation Omnipod Insulin Management System after pausing the study in March due to a software anomaly. The company paused the study about halfway through completion to correct an issue that could result in the system using an incorrect glucose value that had the potential […]
Livongo announces $400m offering
Livongo Health (NSDQ:LVGO) announced that it intends to offer $400 million in a private offering of convertible senior notes. Mountain View, Calif.-based Livongo also plans to grant the initial purchasers of the notes, due in 2025, a 13-day option to purchase up to an additional $60 million, according to a news release. The notes will be […]